TGFBR3, a receptor for TGF‐β, is implicated in various cancers, including breast cancer, melanoma, prostate cancer, pancreatic cancer, colon cancer, multiple myeloma, neuroblastoma, ovarian cancer, endometrial cancer, and lung cancer.34, 35, 36, 37, 38. The gene discussed is TGFB1; the disease is ovarian cancer.